MedTrace Logo

Endoscopic Radiofrequency Ablation Versus Hybrid Argon Plasma Coagulation in the Treatment of Barrett's Esophagus

NCT05051475 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 62

Last updated 2025-10-03

No results posted yet for this study

Summary

This study compares patients' acceptability and safety of two established endoscopic methods for treating dysplastic Barrett's esophagus: radiofrequency ablation versus hybrid argon plasma coagulation.

Conditions

  • Barrett Esophagus
  • Esophageal Adenocarcinoma
  • Reflux Disease

Interventions

PROCEDURE

Endoscopic radiofrequency ablation

Endoscopic ablation technique for Barrett's epithelium

PROCEDURE

Endoscopic hybrid argon plasma coagulation

Endoscopic ablation technique for Barrett's epithelium

Sponsors & Collaborators

  • Maria Sklodowska-Curie National Research Institute of Oncology

    collaborator OTHER

  • Centre of Postgraduate Medical Education

    lead OTHER

Principal Investigators

  • Wladyslaw Januszewicz, MD · Centre for Postgraduate Medical Education

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-01
Primary Completion
2025-05-05
Completion
2025-05-05

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05051475 on ClinicalTrials.gov